The BIA has responded to the Financial Conduct Authority's consultations related to patient capital, covering authorised funds and permitted links rules.
28 Jan 19
Regulatory, Finance Tax Investment, Pre Clinical And Clinical Research, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent, Access To Medicines, Policy Briefing
The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from October 2018 to January 2019.